Pierre Ducrot

Title: Pierre Ducrot: Innovator in Phosphodiesterase Inhibitors

Introduction

Pierre Ducrot is a notable inventor based in Verrieres le Buisson, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase inhibitors. With a total of four patents to his name, Ducrot's work has the potential to impact therapeutic approaches for various disorders.

Latest Patents

Ducrot's latest patents include innovative compounds that serve as phosphodiesterase-7 inhibitors. One of his notable inventions is titled "Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors." This invention provides compounds that are PDE7 inhibitors, characterized by specific formulas defined in the patent description. Another significant patent is "Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors," which details 1,3,4-thiadiazoles and 1,3,4-oxadiazoles with therapeutic applications.

Career Highlights

Throughout his career, Ducrot has worked with prominent companies, including Warner-Lambert Company and Warner Lambert LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Ducrot has collaborated with several professionals in his field, including Patrick Bernardelli and Fabrice Vergne. These collaborations have likely enhanced his research and development efforts in creating effective pharmaceutical compounds.

Conclusion

Pierre Ducrot is a distinguished inventor whose work in phosphodiesterase inhibitors showcases his innovative spirit and dedication to advancing medical science. His contributions continue to pave the way for new therapeutic options.